anti fyn mab (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
95
Structured Review
Cell Signaling Technology Inc
anti fyn mab
Anti Fyn Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 303 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+fyn/Fyn+Antibody/pm41914886-220-6-8
Average 95 stars, based on 303 article reviews
Anti Fyn Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 303 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+fyn/Fyn+Antibody/pm41914886-220-6-8
Average 95 stars, based on 303 article reviews
anti fyn mab - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Western Blot:Article Title: Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer Article Snippet: .. Antibodies used for western blot analysis were: anti-SRC (Santa Cruz biotechnology, mouse sc-5266), Article Title: Methods and compositions for the treatment of amyloid-related disorders Article Snippet: Immunoblots Proteins were electrophoresed through precast 4-20% tris-glycine gels (Bio-Rad) and transferred with an iBlotTM Gel Transfer Device (Novex-Life Technologies) onto nitrocellulose membranes (Invitrogen). .. Membranes were blocked in blocking buffer for fluorescent western blotting (Rockland MB-070-010) for 1 hour at room temperature and incubated overnight in primary antibodies at 4° C. The following primary antibodies were used: other:Article Title: Fyn inhibition by TAE684: A synergistic strategy to suppress melanoma and reverse vemurafenib resistance. Article Snippet: Anti-Fyn (4023), anti-pHistone H2A.X (9718), anti-p53(2527), anti-phospho-p53 (Ser33) (2526), anti-p21 (2947), anti-c-Jun (9165), Article Title: Fyn inhibition by TAE684: A synergistic strategy to suppress melanoma and reverse vemurafenib resistance Article Snippet: Anti-Fyn (4023), anti-p-Histone H2A.X (9718), anti-p53(2527), anti-phospho-p53 (Ser33) (2526), anti-p21 (2947), anti-c-Jun (9165), Incubation:Article Title: Triptolide derivative STP1 ameliorates murine systemic lupus erythematosus via targeting Fyn kinase. Article Snippet: Triptolide has demonstrated potent immunosuppressive properties in multiple autoimmune disorders, but its severe toxicity has greatly hampered clinical application.. Here, we synthesized a triptolide derivative STP1, which exhibits remarkably reduced toxicity compared with triptolide.. Immune dysfunction plays a critical role in systemic lupus erythematosus (SLE), an archetypical and refractory autoimmune disorder with limited therapeutic options and suboptimal outcomes. Article Title: Methods and compositions for the treatment of amyloid-related disorders Article Snippet: Immunoblots Proteins were electrophoresed through precast 4-20% tris-glycine gels (Bio-Rad) and transferred with an iBlotTM Gel Transfer Device (Novex-Life Technologies) onto nitrocellulose membranes (Invitrogen). .. Membranes were blocked in blocking buffer for fluorescent western blotting (Rockland MB-070-010) for 1 hour at room temperature and incubated overnight in primary antibodies at 4° C. The following primary antibodies were used: Blocking Assay:Article Title: Methods and compositions for the treatment of amyloid-related disorders Article Snippet: Immunoblots Proteins were electrophoresed through precast 4-20% tris-glycine gels (Bio-Rad) and transferred with an iBlotTM Gel Transfer Device (Novex-Life Technologies) onto nitrocellulose membranes (Invitrogen). .. Membranes were blocked in blocking buffer for fluorescent western blotting (Rockland MB-070-010) for 1 hour at room temperature and incubated overnight in primary antibodies at 4° C. The following primary antibodies were used: Imaging:Article Title: Methods and compositions for the treatment of amyloid-related disorders Article Snippet: Immunoblots Proteins were electrophoresed through precast 4-20% tris-glycine gels (Bio-Rad) and transferred with an iBlotTM Gel Transfer Device (Novex-Life Technologies) onto nitrocellulose membranes (Invitrogen). .. Membranes were blocked in blocking buffer for fluorescent western blotting (Rockland MB-070-010) for 1 hour at room temperature and incubated overnight in primary antibodies at 4° C. The following primary antibodies were used: Activation Assay:Article Title: Mechanistic insights into PPARγ's role in suppressing collagen-driven platelet activation. Article Snippet: The following reagents were used: rosiglitazone and GW9662 (Cat. #71742, 70785; Cayman Chemical, Ann Arbor, MI, USA), 15-deoxyΔ-12,14-prostaglandin J2 (15d-PGJ2) (Cat.#BML-PG050; Biomol, Hamburg, Germany), AEBSF (Cat.#A-540; Gold Biotechnology, St. Louis, MO, USA), aprotinin, glycine, NaCl, NaHCO3, SDS, Tris (Cat. #0332, 0167, 0241, 0335, 0227, 0497) (all from Amresco, Solon, OH, USA), BSA, CaCl2, DMSO (Cat.#A6003-5G, C5670, D8418), EGTA, glucose, (Cat.#E4378, G7021), KH2PO4, Na2HPO4, Na3VO4, Na4P2O7•10H2O, NaF (Cat.#P5655, S9763, S6508, S6422, S7920), prostaglandin E1, sodium citrate, Triton X-100, β-glycerophosphate, β-mercaptoethanol (Cat.#P5515, S4641, T9284, G9422, M3148), von Willebrand factor (vWF) (Cat.#681300) (all from Sigma-Aldrich, St. Louis, MO, USA), citric acid (Cat.#4337; Duksan, Seoul, Korea), EDTA, KCl, leupeptin, MgCl2, Tween-20 (Cat.#75829, 74075, 78436, 75826, 20605) (all from USB, Cleveland, OH, USA), collagen type 1 and ristocetin (Cat.#396) (both from Chrono-Log, Havertown, PA, USA), horseradish peroxidase-conjugated anti-rabbit (Cat.#NA934) or anti-mouse IgG (Cat.#NA931) antibodies (both from Amersham Biosciences, Piscataway, NJ, USA), HEPES (Cat.#11344041; Thermo Fisher Scientific, Waltham, MA, USA), protein A or G sepharose Cl–4B (Cat.#17-096303, 17-0780-01; Cytiva, Marlborough, MA, USA), collagen-related peptide-XL (CRP-XL) (Triple Helical Peptides, Cambridge, United Kingdom), eptifibatide (Cat.# HY-B0686) and H89 (Cat.# HY-15979) (both from MedChem Express, Princeton, NJ, USA). .. The following antibodies were used: anti-PPARγ (E-8, Cat.#sc-7273), anti-phospho-Vav1 (Tyr174, Cat.#sc-16,408-R), anti-Syk (clone LR, Cat. #sc-573), anti-Lyn (clone H6, Cat.#sc-7274), agarose-conjugated antiLyn (44, Cat.#sc-15 AC), anti-linker for the activation of T cells (LAT) (clone 11B.12, Cat.#sc-53550), anti-phospho-PLCγ2 (Tyr753, Cat.#sc101785), anti-PLCγ2 (clone Q20, Cat.#sc-407), agarose-conjugated |